Skip to main content
. 2006 Mar;50(3):962–967. doi: 10.1128/AAC.50.3.962-967.2006

TABLE 1.

MICs of β-lactams for M. morganii clinical isolates, derived AmpC hyperproducers, and E. coli strains harboring ampC from M. morganii

Antibiotic(s) MIC (μg/ml) for:
Wild-type strains
AmpC hyperproducers
Escherichia coli strains
PP19 PP29 PP37 PP19C PP29II PP37B TCR192c TC192-2d Top10 F′
Ampicillin 256 64 32 1,024 1,024 512 512 256 2
Ampicillin-clavulanatea 128/64 128/64 64/32 512/256 512/256 256/128 256/128 128/64 2/1
Piperacillin 16 0.25 0.25 >64 32 16 64 32 1
Piperacillin-tazobactamb 1 0.063 0.063 32 8 4 16 8 0.5
Cephalothin >512 >512 >512 >2,048 >2,048 >2,048 >512 256 2
Cefoxitin 32 8 4 64 16 64 64 16 2
Cefotaxime ≤0.032 ≤0.032 ≤0.032 16 4 16 2 0.5 ≤0.032
Ceftazidime 1 0.5 0.5 32 16 64 8 4 0.063
Cefoperazone 1 1 2 32 8 16 0.25 0.25 ≤0.032
Cefepime ≤0.008 ≤0.008 ≤0.008 ≤0.008 ≤0.008 ≤0.008 0.008 0.016 0.016
Imipenem 2 2 2 2 2 1 2 2 0.063
Aztreonam ≤0.032 ≤0.032 ≤0.032 0.5 0.5 0.064 0.5 0.5 0.063
a

Used at a ratio of 2:1.

b

Fixed concentration of 4 μg/ml.

c

Strain harboring pMCR19-2 (ampC, ampR from M. morganii strain PP19).

d

Strain harboring pMC192-2 (ampC from M. morganii strain PP19).